Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
2015ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 62 KB)
PU
2015ASTELLAS PHARMA : Receives FDA Approval for CRESEMBA® (isavuconazonium sulfate) ..
PU
2015ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 63KB)
PU
2015ASTELLAS PHARMA : Launches the Newest Element in its Global Corporate Brand Camp..
PU
2015ASTELLAS PHARMA : Enhancement of Astellas' Management Structure (pdf 82KB)
PU
2015ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes (pdf 98KB..
PU
2015ASTELLAS PHARMA : Graduate School of Medicine/Faculty of Medicine, Osaka Univers..
PU
2015ASTELLAS PHARMA : Broadens commitment to clinical trial data transparency
PU
2015ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 62 KB)
PU
2015ASTELLAS PHARMA : and Immunomic Therapeutics Announce Exclusive License for JRC2..
PU
2015ASTELLAS PHARMA : Announces FDA Anti-Infective Drugs Advisory Committee Recommen..
PU
2014ASTELLAS PHARMA : Data to be presented from phase 2 study of enzalutamide in adv..
PU
2014ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Third Year
PU
2014ASTELLAS PHARMA : Announces End of License Agreement with Janssen to Develop and..
PU
2014ASTELLAS PHARMA : Enzalutamide (xtandi) now approved in europe for the treatment..
PU
2014ASTELLAS PHARMA : announces termination of Amgen-sponsored clinical studies of r..
PU
2014ASTELLAS PHARMA : The results of Japanese Clinical Trials of Anti-TNF-alpha Anti..
PU
2014ASTELLAS PHARMA : Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global..
PU
2014ASTELLAS PHARMA : DANA-FARBER CANCER INSTITUTE AND ASTELLAS ANNOUNCE - Focus on ..
PU
2014ASTELLAS PHARMA : Proteostasis Therapeutics and Astellas Announce Collaboration ..
PU
2014ASTELLAS PHARMA : Announces Revision of Dividend Forecast (Increase Dividends) f..
PU
2014ASTELLAS PHARMA : Announces Revision of Package Insert in Japan for XTANDI® (enz..
PU
2014ASTELLAS PHARMA : and CoMentis to End Agreement to Collaborate on Research, Deve..
PU
2014ASTELLAS PHARMA : ANNOUNCES RESEARCH COLLABORATION WITH HARVARD MEDICAL SCHOOL I..
PU
2014ASTELLAS PHARMA : promotes employment of people with disabilities by placing the..
PU
2014ASTELLAS PHARMA INC : Ex-dividend day for interim dividend
FA
2014ASTELLAS PHARMA : has been Selected for the Fourth Consecutive Year for the Dow ..
PU
2014ASTELLAS PHARMA : Transfer of Distribution and Termination of Co-promotion for C..
PU
2014UK cancer drug fund gets extra 160 million pounds
RE
2014ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes (pdf 85KB..
PU
2014ASTELLAS PHARMA : Cancer research uk and cancer research technology join forces ..
PU
2014ASTELLAS PHARMA : Submits Supplemental New Drug Application for Irribow®/Irribow..
PU
2014ASTELLAS PHARMA : Submits U.S. New Drug Application for Isavuconazole for the Tr..
PU
2014ASTELLAS PHARMA : Contents of Subscription Rights to Shares (Stock Option Scheme..
PU
2014ASTELLAS PHARMA : Announcement of an Application for the Additional Indication f..
PU
2014ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 62KB)
PU
2014ASTELLAS PHARMA : Allotment of Subscription Rights to Shares (Stock Option Schem..
PU
2014ASTELLAS PHARMA : and UMN Announce Submission of Application for Marketing Appro..
PU
2014ASTELLAS PHARMA : ANNOUNCES GROUNDBREAKING €1.5m PROGRAMME TO TACKLE OBSTETRIC F..
PU
2014ASTELLAS PHARMA : Announces Launch of XTANDI® (enzalutamide) Capsules in Japan f..
PU
2014ASTELLAS PHARMA : Announces Personnel Changes (pdf 42KB)
PU
2014ASTELLAS PHARMA : Announces Cancellation of Treasury Shares (pdf 25KB)
PU
2014ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 63KB)
PU
2014ASTELLAS PHARMA : Announces Issuance of Stock Acquisition Rights for Stock Optio..
PU
2014ASTELLAS PHARMA : Nominates Director and Corporate Auditors (pdf 40KB)
PU
2014ASTELLAS PHARMA : Launch of Suglat® Tablets, a Selective SGLT2 Inhibitor for Tre..
PU
2014ASTELLAS PHARMA : ANNOUNCES MARKETING AUTHORISATION APPLICATION FOR XTANDI&trade..
PU
2014ASTELLAS PHARMA : Establishment of Regenerative Medicine Unit
PU
2014ASTELLAS PHARMA INC : Ex-dividend day for final dividend
FA
2014ASTELLAS PHARMA INC : SPLIT: 5 of 1
FA
2014ASTELLAS PHARMA : Announces Marketing Approval in Japan for XTANDI® (enzalutamid..
PU
2014ASTELLAS PHARMA : Pediatric Praziquantel Consortium awarded US$1.86 million GHIT..
PU
2014ASTELLAS PHARMA : And medivation submit supplemental new drug application for xt..
PU
2014ASTELLAS PHARMA : and Medivation Submit Supplemental New Drug Application for XT..
MW
2014ASTELLAS PHARMA : Awarded Diversity Management Selection 100 (pdf 196KB)
PU
2014ASTELLAS PHARMA INC : Astellas Secures Exclusive Rights to Commercialize Isavuco..
PU
2014ASTELLAS PHARMA INC : Astellas Announces Stock Split and Partial Amendment to th..
PU
2014ASTELLAS PHARMA INC : Reorganization of Astellas' Global Management Structure (p..
PU
2014ASTELLAS PHARMA INC : Approval of Suglat® Tablets, a Selective SGLT2 Inhibitor f..
PU
2014ASTELLAS PHARMA INC : Astellas and UMN Announce Summary Results in Phase III Cli..
PU
2014ASTELLAS PHARMA INC : Astellas Pharma: Launches Irribow® OD Tablets in Japan for..
PU
2014ASTELLAS PHARMA INC : ASTELLAS TO FORM STRATEGIC PARTNERSHIP WITH CLEARPATH TO B..
PU
2013ASTELLAS PHARMA INC : Astellas and IBL Concludes Co-Research Agreement Regarding..
PU
2013ASTELLAS PHARMA INC : Approval of Additional Indication for Hypnosedative, Dormi..
PU
2013ASTELLAS PHARMA INC : Production Subsidiary Astellas Pharma Tech Concludes Defin..
PU
2013ASTELLAS PHARMA INC : Notice of Completion of Acquisition of Own Shares
PU
2013ASTELLAS PHARMA INC : Astellas Concludes Agreement with Mitsui Fudosan Comprehen..
PU
2013ASTELLAS PHARMA INC : Astellas signs agreement with Accenture for Business Proce..
PU
2013ASTELLAS PHARMA INC : Astellas Announces Acquisition of Own Shares (pdf 75KB)
PU
2013ASTELLAS PHARMA INC : Medivation and Astellas Announce The Phase 3 PREVAIL Trial..
PU
2013ASTELLAS PHARMA INC : Astellas and UMN announce Completion of Administration of ..
PU
2013ASTELLAS PHARMA INC : ASTELLAS AND MITOKYNE TO PURSUE MITOCHONDRIA-RELATED DISEA..
PU
2013ASTELLAS PHARMA INC : Establishment of New Organization to enhance the ability t..
PU
2013ASTELLAS PHARMA INC : Production Subsidiary Astellas Pharma Tech Concludes Basic..
PU
2013ASTELLAS PHARMA INC : Ex-dividend day for interim dividend
FA
Prev.1  2  3  4  5   6  7  8Next
Upcoming event on ASTELLAS PHARMA INC.